(Q38598335)

4 September 2017

Update of HIV-Associated Sensory Neuropathies (English)

1 reference

4 September 2017

Angela Aziz-Donnelly

1

1 reference

PubMed ID

28861848

4 September 2017

Taylor B Harrison

series ordinal

2

1 reference

4 September 2017

31 August 2017

1 reference

Current treatment options in neurology

4 September 2017

1 reference

4 September 2017

19

1 reference

4 September 2017

10

1 reference

4 September 2017

36

1 reference

https://scigraph.springernature.com/pub.10.1007/s11940-017-0472-3

4 September 2017

0 references

cites work

2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Markers of immune activation and viral load in HIV-associated sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Epidemiology of HIV-related neuropathy: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Abnormalities of peripheral nerve in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Peripheral neuropathy in ART-experienced patients: prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Peripheral neuropathy in HIV: prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Patterns of peripheral neuropathy in ART-naïve patients initiating modern ART regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Differences in human immunodeficiency virus care and treatment among subpopulations in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

HIV neuropathy: insights in the pathology of HIV peripheral nerve disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Pathogenesis of HIV-associated sensory neuropathy: evidence from in vivo and in vitro experimental models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

α4-Integrin Antibody Treatment Blocks Monocyte/Macrophage Traffic to, Vascular Cell Adhesion Molecule-1 Expression in, and Pathology of the Dorsal Root Ganglia in an SIV Macaque Model of HIV-Peripheral Neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

An oral form of methylglyoxal-bis-guanylhydrazone reduces monocyte activation and traffic to the dorsal root ganglia in a primate model of HIV-peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Spatially distinct and functionally independent mechanisms of axonal degeneration in a model of HIV-associated sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

The Molecular and Pharmacological Mechanisms of HIV-Related Neuropathic Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

HIV treatment and associated mitochondrial pathology: review of 25 years of in vitro, animal, and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Mitochondrial dysfunction in distal axons contributes to human immunodeficiency virus sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and predicts an individual's NRTI-SN risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

A rodent model of HIV protease inhibitor indinavir induced peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

HIV Distal Neuropathic Pain Is Associated with Smaller Ventral Posterior Cingulate Cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Antiretroviral therapy may improve sensory function in HIV-infected patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Distal leg epidermal nerve fiber density as a surrogate marker of HIV-associated sensory neuropathy risk: risk factors and change following initial antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Unhealthy behaviours for self-management of HIV-related peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Symptom management and self-care for peripheral neuropathy in HIV/AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Topical capsaicin in the management of HIV-associated peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Peptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trial. The Peptide T Neuropathy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Mexiletine for HIV-infected patients with painful peripheral neuropathy: a double-blind, placebo-controlled, crossover treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Experience and challenges presented by a multicenter crossover study of combination analgesic therapy for the treatment of painful HIV-associated polyneuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Morphine, gabapentin, or their combination for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Prevalence, self-care behaviors, and self-care activities for peripheral neuropathy symptoms of HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Effect of acupuncture administered in a group setting on pain and subjective peripheral neuropathy in persons with human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Hypnosis for treatment of HIV neuropathic pain: a preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

The effects of progressive-resisted exercises on muscle strength and health-related quality of life in persons with HIV-related poly-neuropathy in Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Randomized Trial of Lower Extremity Splinting to Manage Neuropathic Pain and Sleep Disturbances in People Living with HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Placebo response changes depending on the neuropathic pain syndrome: results of a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

HIV neuropathy natural history cohort study: Assessment measures and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-017-0472-3

Total neuropathy score: validation and reliability study

21 January 2018

1 reference

12 December 2020

Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines.

1 reference

12 December 2020

Fulminant neuropathy and lactic acidosis associated with nucleoside analog therapy

1 reference

12 December 2020

Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy: an autopsy-based case-control study

1 reference

12 December 2020

Neuromuscular function in HIV infection: analysis of a placebo-controlled combination antiretroviral trial. AIDS Clinical Group 175/801 Study Team

1 reference

12 December 2020

Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy

1 reference

12 December 2020

A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291

1 reference

12 December 2020

1 reference

12 December 2020

Peripheral neuropathy in lentivirus infection

1 reference

12 December 2020

Incidence of and risk factors for HIV-associated distal sensory polyneuropathy

1 reference

12 December 2020

Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons

1 reference

12 December 2020

Peripheral neuropathy in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Increased NADPH-diaphorase reactivity and cytokine expression in dorsal root ganglia in acquired immunodeficiency syndrome

1 reference

12 December 2020

HIV-1 peripheral neuropathy and combination antiretroviral therapy

1 reference

12 December 2020

Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection

1 reference

12 December 2020

Expression of HIV-1 and interleukin-6 in lumbosacral dorsal root ganglia of patients with AIDS

1 reference

12 December 2020

10.1007/S11940-017-0472-3

Identifiers

DOI

1 reference

4 September 2017

1 reference

PubMed ID

28861848